Background: Diabetes type 2 is the basic problem in the diabetic science due to several reasons, such as the unexplained etiology and pathogenesis of the disease and therapy. The most important problem in treating the disease, remains the insulin resistance, possibly, due the inability to be explained, it will remain a long time in the realm of speculation and in the area of trials and efforts of the pharmaceutical industries in order to find the right therapy. The main aim of the project is the definition of the main reason for increasing the number of suffering from diabetes mellitus as well as determining the type of the most commonly used therapeutic techniques in Shtip (R. of Macedonia) diabetes center between 2005 and 2009th. Methods...
An incidence of diabetes is right away growing everywhere in the world at the startling rate. For th...
The aim of this study: To investigate the need for pharmaceutical information of patients with type ...
Background. The early prescription of a combination of extended-release metformin with glimepiride i...
The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diab...
TYPE 2 DIABETES – PATHOPHYSIOLOGY AND MEDICAMENTAL TREATMENT Background: Diabetes mellitus, especi...
Diabetes mellitus is a chronic disease that occurs when the pancreas does not produce enough insulin...
Diabetes mellitus is a chronic disease that occurs when the pancreas does not produce enough insulin...
peer reviewedType 2 diabetes is a heterogeneous disease resulting from a dynamic interaction between...
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder in which prevalence has been increasin...
objective. The aim of the research was to evaluate the level of patients' knowledge about type 2 dia...
Type 2 diabetes is a heterogeneous disease resulting from a dynamic interaction between defects in i...
PHARMACOTHERAPY ANALYSIS OF DIABETES MELLITUS IN DIABETOLOGIC CONSULTING ROOM Student: Buriankova L....
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in i...
Type 2 diabetes mellitus is a metabolic disorder that is becoming more and more common everywhere in...
An incidence of diabetes is right away growing everywhere in the world at the startling rate. For th...
An incidence of diabetes is right away growing everywhere in the world at the startling rate. For th...
The aim of this study: To investigate the need for pharmaceutical information of patients with type ...
Background. The early prescription of a combination of extended-release metformin with glimepiride i...
The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diab...
TYPE 2 DIABETES – PATHOPHYSIOLOGY AND MEDICAMENTAL TREATMENT Background: Diabetes mellitus, especi...
Diabetes mellitus is a chronic disease that occurs when the pancreas does not produce enough insulin...
Diabetes mellitus is a chronic disease that occurs when the pancreas does not produce enough insulin...
peer reviewedType 2 diabetes is a heterogeneous disease resulting from a dynamic interaction between...
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder in which prevalence has been increasin...
objective. The aim of the research was to evaluate the level of patients' knowledge about type 2 dia...
Type 2 diabetes is a heterogeneous disease resulting from a dynamic interaction between defects in i...
PHARMACOTHERAPY ANALYSIS OF DIABETES MELLITUS IN DIABETOLOGIC CONSULTING ROOM Student: Buriankova L....
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in i...
Type 2 diabetes mellitus is a metabolic disorder that is becoming more and more common everywhere in...
An incidence of diabetes is right away growing everywhere in the world at the startling rate. For th...
An incidence of diabetes is right away growing everywhere in the world at the startling rate. For th...
The aim of this study: To investigate the need for pharmaceutical information of patients with type ...
Background. The early prescription of a combination of extended-release metformin with glimepiride i...